• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Gasporox

7.05 SEK

+3.68 %

Less than 1K followers

GPX

First North Stockholm

Hardware Manufacturer

Technology

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+3.68 %
-12.96 %
-3.42 %
-5.75 %
-5.75 %
-7.24 %
-52.04 %
-31.55 %
-32.44 %

Gasporox is a technology company that offers products for quality control of packaging in the pharmaceutical, food and beverage industries. Gasporox products are completely non-destructive and can be integrated directly into production lines. The technology, based on laser spectroscopy, measures gas content in the packaging. Customer groups include both producing factories and machine manufacturers that integrate the company's products. The company operates in the global market and is headquartered in Lund.

Read more
Market cap
65.94M SEK
Turnover
30.59K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
11.8.
2026

Interim report Q2'26

22.10.
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release25.10.2024 klo 11.01

Redeye: Gasporox - LTM reacceleration expected in Q1 2025

Gasporox
Press release08.08.2024 klo 09.58

Redeye: Gasporox - Close to sustained profitability

Gasporox
Press release23.04.2024 klo 15.29

Redeye: Gasporox - Executing its long-term strategy

Gasporox

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release16.02.2024 klo 09.08

Redeye: Gasporox - Orders up, but earnings linger for 2024

Gasporox
Press release08.11.2023 klo 10.16

Redeye: Gasporox - Catching its breath after a strong H1 2023

Gasporox
Press release10.08.2023 klo 08.30

Redeye: Gasporox Q2 2023 - Sharp performance across the board

Gasporox
Press release28.04.2023 klo 08.55

Redeye: Gasporox - Best quarter yet

Gasporox
Press release01.03.2023 klo 11.46

Redeye: Gasporox - Managed for long-term value creation

Gasporox
Press release14.11.2022 klo 08.19

Redeye: Gasporox - Keeping its Phot-on the Gas

Gasporox
Press release02.09.2022 klo 08.32

Redeye: Redeye Initiates Coverage of Gasporox

Gasporox
Regulatory press release22.01.2019 klo 14.30

Powerful investment in GASPOROX subsidiary GPX Medical, the Board recruits Hanna Sjöström as new CEO from January 28, 2019

Gasporox